ArticleInternational journal of clinical oncology2019

Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer.

Ayako Tsuboya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.